{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T21:37:33Z","timestamp":1768685853743,"version":"3.49.0"},"reference-count":10,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDS"],"published-print":{"date-parts":[[2019,5,22]]},"abstract":"<jats:sec>\n<jats:title>Introduction:<\/jats:title><jats:p> Imatinib is the treatment of choice in patients with locally advanced or metastatic\ngastrointestinal stromal tumours (GIST). Clinical tolerance of imatinib is excellent except for the\ncommon adverse drug reaction (ADR). Drug rash with eosinophilia and systemic symptoms (DRESS\nsyndrome) is a severe, potentially life-threatening drug-induced hypersensitivity reaction, characterized\nby cutaneous eruptions, fever, diffuse lymphadenopathy, along with eosinophilia, and elevated\nliver function tests. This ADR is rarely reported with imatinib. Only four cases of DRESS syndrome\nassociated with imatinib have already been published.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Case Report:<\/jats:title><jats:p>We report an exceptional case of DRESS syndrome associated with imatinib in a 46\nyear-old woman with GIST. Two weeks after she had started imatinib therapy, she developed a skin\nrash, with eosinophilia and elevated liver tests. Plasma level of imatinib was within the therapeutic\nrange. Imatinib was immediately discontinued. A favourable outcome was slowly observed after the\ndrug had been stopped.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results and Conclusion:<\/jats:title><jats:p> This case was scored three according to the European Registry of Severe Cutaneous\nAdverse Reactions Study Group (RegiSCAR). The Naranjo score for imatinib was five (probable).<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1574886314666190130150243","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T11:06:29Z","timestamp":1549019189000},"page":"151-154","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Induced by Imatinib"],"prefix":"10.2174","volume":"14","author":[{"given":"F.","family":"Zgolli","sequence":"first","affiliation":[{"name":"National Center Chalbi Belkahia of Pharmacovigilance, 9 Avenue du Dr Zouhaier Essafi 1006, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Aouinti","sequence":"additional","affiliation":[{"name":"National Center Chalbi Belkahia of Pharmacovigilance, 9 Avenue du Dr Zouhaier Essafi 1006, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Charfi","sequence":"additional","affiliation":[{"name":"National Center Chalbi Belkahia of Pharmacovigilance, 9 Avenue du Dr Zouhaier Essafi 1006, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Badri","sequence":"additional","affiliation":[{"name":"University of Tunis El Manar, Faculty of Medicine, Research unit: UR17ES12, 15 Rue Djebel Lakhdhar, La Rabta, 1007, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Elaidli","sequence":"additional","affiliation":[{"name":"National Center Chalbi Belkahia of Pharmacovigilance, 9 Avenue du Dr Zouhaier Essafi 1006, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kastalli","sequence":"additional","affiliation":[{"name":"National Center Chalbi Belkahia of Pharmacovigilance, 9 Avenue du Dr Zouhaier Essafi 1006, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Lakhoua","sequence":"additional","affiliation":[{"name":"National Center Chalbi Belkahia of Pharmacovigilance, 9 Avenue du Dr Zouhaier Essafi 1006, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Za\u00efem","sequence":"additional","affiliation":[{"name":"National Center Chalbi Belkahia of Pharmacovigilance, 9 Avenue du Dr Zouhaier Essafi 1006, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2147\/TCRM.S1526","volume":"4","author":"Din O.S.","year":"2008","unstructured":"Din OS, Woll PJ. Ther Clin Risk Manag, Treatment of gastrointestinal stromal tumor: Focus on imatinib mesylate.,, 2008, 4,, 149-162,","journal-title":"Ther Clin Risk Manag"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1634\/theoncologist.9-3-271","volume":"9","author":"Guilhot F.","year":"2004","unstructured":"Guilhot F. Oncologist, Indications for imatinib mesylate therapy and clinical management.,, 2004, 9,, 271-281,","journal-title":"Oncologist"},{"key":"ref=3","author":"Sweetman S.C.","unstructured":"Sweetman SC, , ,, , In: Martindale. The complete drug reference. Pharmaceutical Press 36th ed. London: press UK., , ,-"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jbspin.2013.05.002","volume":"81","author":"Descamps V.","year":"2014","unstructured":"Descamps V, Ranger-Rogez S. Joint Bone Spine, DRESS syndrome.,, 2014, 81,, 15-21,","journal-title":"Joint Bone Spine"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"Naranjo C.A.","year":"1981","unstructured":"Naranjo CA, Busto U, Sellars EM. Clin Pharmacol Ther, A method for estimating the probability of adverse drug reactions.,, 1981, 30,, 239-245,","journal-title":"Clin Pharmacol Ther"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.annder.2007.10.007","volume":"135","author":"Goldman J.","year":"2008","unstructured":"Goldman J, Duval-Modeste AB, Lambert A. Ann Dermatol Venereol, Imatinib induced DRESS.,, 2008, 135,, 393-396,","journal-title":"Ann Dermatol Venereol"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.4103\/2229-5178.146189","volume":"5","author":"Kumar M.","year":"2014","unstructured":"Kumar M, Mandal PK, Dolai TK, Bhattacharrya M. Indian Dermatol Online J, Imatinib causing drug rash with eosinophilia and systemic symptoms: A rare cutaneous reaction.,, 2014, 5,, S120-S122,","journal-title":"Indian Dermatol Online J"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/10428194.2016.1201575","volume":"58","author":"Vatel O.","year":"2017","unstructured":"Vatel O, Aumont C, Mathy V. Leuk Lymphoma, Drug reaction with eosinophilia and systemic symptoms (DRESS) induced by imatinib in chronic myeloid leukemia.,, 2017, 58,, 473-474,","journal-title":"Leuk Lymphoma"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4103\/0378-6323.198452","volume":"83","author":"Saidi W.","year":"2017","unstructured":"Saidi W, Lahouel I, Laarif M, Aounallah A. Indian J Dermatol Venereol Leprol, A new case of imatinib-induced drug reaction with eosinophilia and systemic symptoms.,, 2017, 83,, 224-226,","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref=10","author":"Fregert S.","unstructured":"Fregert S, , Munksgaard,, Copenhagen, 2nd ed, Manual of contact dermatitis., 1981,71-76","journal-title":"Manual of contact dermatitis"}],"container-title":["Current Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/169478","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T06:10:36Z","timestamp":1560838236000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/169478\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,22]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,5,22]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574886314666190130150243","relation":{},"ISSN":["1574-8863"],"issn-type":[{"value":"1574-8863","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,22]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-10-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}